National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge

Journal of Attention Disorders

Volumn 7, Issue 4, 2004, Pages 217-226

  Bhatara, Vinod ^a,f   Feil, Michael ^b   Hoagwood, Kimberly ^c   Vitiello, Benedetto ^d   Zima, Bonnie ^e  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e UCLA Health Services Research Center   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; FLUOXETINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PEMOLINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; HEALTH STATISTICS; HEALTH SURVEY; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MONOTHERAPY; NEUROMODULATION; PRESCRIPTION; PSYCHIATRIC TREATMENT; SCHOOL CHILD;

EID: 3042791262     PISSN: 10870547     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705470400700404     Document Type: Article

References (48)

1. American Academy of Pediatrics, Subcommittee on ADHD and Committee on Quality Improvement (2001). Clinical practice guidelines: Treatment of the school-aged children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 108, 1033-1044.
2. Barret, J., Meehan, O., & Fahy, T. (1996). SSRI and sympathomimetic interaction. British Journal of Psychiatry, 168, 253 (letter).
3. Bhatara, V. S., Feil, M., Hoagwood, K., Vitiello, B., & Zima, B. (2002). Datapoints: Trends in combined pharmacotherapy with stimulants for children. Psychiatric Services, 53, 244.
4. Bhatara, V. S., Kallepalli, B., Misra, L., & Awadallah, S.(1996). A possible clonidine-trazodone-dextroamphetamine interaction in a 12-year-old boy. Journal of Child and Adolescent Psychopharmacology, 6, 203-209.
5. Bhatara, V. S., Magnus, R. D., Paul, K. L., & Preskorn, S. H. (1998). Serotonin syndrome induced by venlafaxine and fluoxetine: A case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms. Annals of Pharmacotherapy, 32, 432-436.
6. Bussing, R., & Levin, G. M. (1993). Methamphetamine and fluoxetine treatment of a child with attention deficit hyperactivity disorder and obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 3, 53-58.
7. Carlson, G. A., Rapport, M. D., Kelly, K., & Pataki, C. (1995). Methylphenidate and desipramine in hospitalized children with comorbid behavior and mood disorders: Separate and combined effects on behavior and mood. Journal of Child and Adolescent Psychopharmacology, 5, 191-204.
8. Cohen, L. G., Prince, J., Biederman, J., Wilens, T., Farone, S. V., Whitt, S., et al., (1999). Absence of effects of stimulants on the pharmacokinetics of desipramine in children. Pharmacotherapy, 19, 746-752.
9. Connor, D. F., Barkley, R. A., & Davis, H. (2000). Apilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clinical Pediatrics, 39, 15-25.
10. DeVane, C. L., Markowitz, J., Carson, S., Boulton, D., Gill, H. S., Nahas, Z., et al. (2000). Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers. Journal of Clinical Psychopharmacology, 20, 347-349.
11. Findling, R. L. (1996). Open-label treatment of comorbid depression and attentional disorders with coadministration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series. Journal of Child and Adolescent Psychopharmacology, 6, 165-175.
12. Flemenbaum, A. (1972). Hypertensive episodes after adding methylphenidate (Ritalin) to tricyclic antidepressants. Psychosomatics, 13, 265-268.
13. Gammon, G. D., & Brown, T. E. (1993). Fluoxetine and methylphenidate in combination for treatment of attention deficit and comorbid depressive disorder. Journal of Child and Adolescent Psychopharmacology, 3, 1-10.
14. Greenhill, L. L., Pliszka, S., Ducan, M. K., Bernet, W., Arnold, V., Beitchman, J., et al. (2002). Practice parameters for the use of stimulants medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41 (Suppl.2) 26S-49S.
15. Guyatt, G. H., Haynes, R. B., Jaeschke, R. Z., Cook, D. J., Green, L., Naylor, C. D., et al. (2000). User's guide to medical literature XXV. Evidence-based medicine: Principles for applying the user's guide to patient care. Journal of the American Medical Association, 284, 1290-1296.
16. Hazell, P. L., & Stuart, J. E. (2003). A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 886-894.
17. Hoagwood, K., Jensen, P. S., Feil, M., Vitiello, B., & Bhatara, V. S. (2000). Management of stimulants and other psychotropics in pediatric practice. Journal of Developmental and Behavioral Pediatrics, 21, 322-331.
18. Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J., Gavaghan, D. J., et al. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials, 17, 1-12.
19. Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for U. S. children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 557-565.
20. Lavretsky, H., Kim, M. D., Kumar, A., & Reynolds, C. F. (2003). Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: An open trial. Journal of Clinical Psychiatry, 64, 1410-1414.
21. Markowitz, J. S., & Patrick, K. S. (2001). Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. Clinical Pharmacokinetics, 40, 753-772.
22. MTA Cooperative Group (1999). A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. The MTA Group multimodal treatment study of children with ADHD. Archives of General Psychiatry, 56, 1073-1086.
23. Nass, R., & Bressman, S. (2002). Attention deficit hyperactivity disorder and Tourette syndrome: What's the best treatment? Neurology, 58, 513-514.
24. nd, 2000 from www.cdc.gov/nchs/about/ major/ahcd/sampnam.htm.
25. Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514-521.
26. Parraga, H. C., Kelly, D., Parraga, M., Cochran, M., & Maxim, L. (1994). Combined psychostimulant and tricyclic antidepressant treatment of Tourette's syndrome and comorbid disorders in children. Journal of Child and Adolescent Psychopharmacology, 4, 113-122.
27. Pliszka, S. R. (2003). Psychiatric comorbidities in children with attention deficit hyperactivity disorder: Implications for management. Paediatric Drugs, 5, 741-750.
28. Pliszka, S. R., Greenhill, L. L., Crismon, M. L., Sedillo, A., Carlson, C., Conners, C. K., et al. (2000a). The Texas children's medication algorithm project: Report of the Texas consensus conference panel on medication treatment of childhood Attention-Deficit/Hyperactivity Disorder. Part I. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 908-919.
29. Pliszka, S. R., Greenhill, L. L., Crismon, M. L., Sedillo, A., Carlson, C., Conners, C. K., et al. (2000b). The Texas children's medication algorithm project. Report of the Texas consensus conference panel: Medication treatment of childhood attention deficit/hyperactivity disorder. Part II: Tactics. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 920-927.
30. Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., & Wozniak, J. R. (1996). Clonidine for sleep disturbance associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 599-605.
31. Regino, R., Barren, M., Connor, D. F., & Swanson, J. M. (2000). Patterns of use of clonidine alone and in combination with methylphenidate. In L. Greenhill & B. Osman (Eds.), Ritalin: Theory and practice, 2nd ed. pp. 401-400. New York: Mary Ann Liebert Publishers.
32. Research Triangle Institute (2003). SUDAAN v8.0. Research Triangle Park, NC: Research Triangle Institute.
33. Rushton, J. L., & Whitmore, J. T. (2001). Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Archives of Pediatric and Adolescent Medicine, 155, 560-565.
34. Safer, D. J., Zito, J. M., & dosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160, 438-449.
35. Tourette's Syndrome Study Group (2002). Treatment of ADHD in children with tics: A randomized controlled trial. Neurology, 58, 527-536.
36. Varley, C. K. (2000). Sudden death of a child treated with imipramine. Case study. Journal of Child and Adolescent Psychopharmacology, 10, 321-325.
37. Wilens, T. E., Spencer, T. E., Swanson, J. M., Connor, D. F., & Cantwell, D. (1999). Combining methylphenidate and clonidine: A clinically sound medication option. Journal of American Academy of Child and Adolescent Psychiatry, 38, 614-619.
38. Wolraich, M. (2002). Current assessment and treatment practices in ADHD. In P. S. Jensen & J. R. Cooper (Eds.), Attention-Deficit/Hyperactivity Disorder: State of the Science: Best practices (pp. 23/1-23/10). Kingston NJ: Civic Research Institute.
39. Woodwell, D. A. (1997). National Ambulatory Medical Care Survey: 1995 summary. Advance Data, 286, 1-25.
40. Woodwell, D. A. (1999). National Ambulatory Medical Care Survey: 1997 summary. Advance Data, 305, 1-28.
41. Woodwell, D. A. (2000), National Ambulatory Medical Care Survey: 1998 summary. Advance Data, 315, 1-26.
42. Woodwell, D. A., & Shappert, S. M. (1995). National Ambulatory Medical Care Survey: 1993 summary. Advance Data, 270, 1-20.
43. Woolston, J. L. (1999). Combined pharmacotherapy: Pitfalls of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1455-1457.
44. Zito, J. M., & Safer, D. J. (1997). Sources of data for pharmacoepidemiological studies of child and adolescent psychiatric disorders. Journal of Child and Adolescent Psychopharmacology, 7, 237-253.
45. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., et al. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatric and Adolescent Medicine, 157, 17-25.
46. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Soeken, K., Boles, M., et al. (2002). Rising prevalence of antidepressants among US youths. Pediatrics, 109, 721-727.
47. Zito, J. M., Safer, D. J., dosReis, S., Magder, L., Gardner, J. F., & Zarin, D. A. (1999). Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Archives of Pediatric and Adolescent Medicine, 153, 1257-1263.
48. Zito, J. M., Safer, D. J., Riddle, M. A., Johnson, R. E., Speedie, S. M., & Fox, M. (1998). Prevalence variations in psychotropic treatment of children. Journal of Child and Adolescent Psychopharmacology, 8, 99-105.